Clinical Trial Update: Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin to reduce cardiac toxicity in breast cancer; the study was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Tumors

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Avera McKennan Hospital & University Health Center | Conditions: Breast Cancer, Breast Tumors | Phase 2 | Status: TERMINATED | Results posted: 2019-10-16